Dehydrated amniotic membrane patch for the treatment of an ocular event secondary to mirvetuximab soravtansine-gynx (MIRV) therapy.
Saved in:
| Title: | Dehydrated amniotic membrane patch for the treatment of an ocular event secondary to mirvetuximab soravtansine-gynx (MIRV) therapy. |
|---|---|
| Authors: | File B; Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange, CA, USA., Hari A; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA, USA., Bei L; Department of Ophthalmology, Long Beach Memorial Medical Center, Long Beach, CA, USA. |
| Source: | Gynecologic oncology reports [Gynecol Oncol Rep] 2024 Nov 19; Vol. 56, pp. 101547. Date of Electronic Publication: 2024 Nov 19 (Print Publication: 2024). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2352-5789 |
|---|---|
| DOI: | 10.1016/j.gore.2024.101547 |
